Form 6-K ASTRAZENECA PLC For: Oct 02
FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For the
month of October 2026
Commission
File Number: 001-11960
AstraZeneca PLC
1
Francis Crick Avenue
Cambridge
Biomedical Campus
Cambridge
CB2 0AA
United
Kingdom
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form... (continue reading...)
Form 8-K ACCO BRANDS Corp For: Oct 02
0000712034false00007120342026-10-022026-10-02
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 02, 2026
ACCO Brands Corporation
(Exact name of Registrant as Specified in Its Charter)
Delaware
... (continue reading...)
Form 6-K DRDGOLD LTD For: Jun 30
SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549______________________FORM 6-KREPORT OF A FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-16UNDER THE SECURITIES EXCHANGE ACT OF 1934October 2, 2026Commission File Number 0-28800______________________DRDGOLD LimitedConstantia Office ParkCnr 14th Avenue and Hendrik Potgieter RoadCycad House, Building 17, Ground FloorWeltevreden Park 1709(Address of principal executive offices)______________________Indicate by... (continue reading...)
Form 6-K RYANAIR HOLDINGS PLC For: Oct 02
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the
month of October 2026
RYANAIR HOLDINGS PLC
(Translation
of registrant's name into English)
c/o Ryanair Ltd Corporate Head Office
Dublin Airport
County Dublin Ireland
(Address
of principal executive offices)
Indicate
by... (continue reading...)
Form 8-K NETSTREIT Corp. For: Sep 28
false
0001798100
0001798100
2026-09-28
2026-09-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR... (continue reading...)
More SEC Filings
View Older Stories-
Form 10-Q Trilogy Metals Inc. For: Aug 31
-
Form 8-K Nova Minerals Corp For: Oct 02
-
Form 6-K BANK OF NOVA SCOTIA For: Oct 02
-
Form 20-F DRDGOLD LTD For: Jun 30
-
Form 13F-HR REYL & Cie S.A. For: Jun 30
-
Form 6-K INTERCONTINENTAL HOTELS For: Oct 02
-
Form 144 Masonglory Ltd Filed by: Fung & Tun Ltd
-
Form 144 Melco Resorts & Entertai Filed by: WINKLER EVAN ANDREW
-
Form SCHEDULE 13D Zedge, Inc. Filed by: JONAS HOWARD S
-
Form D Confirm Global, Inc.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K TNL Mediagene For: Oct 02
-
Form D/A Bettor Capital Fund II-A
-
Form 8-K Seritage Growth Properti For: Sep 30
-
Form D/A Bettor Capital Fund II,
-
Form 6-K Reitar Logtech Holdings For: Oct 02
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 144 Enlight Renewable Energy Filed by: Goren Ilan
-
Form 144 Freightos Ltd Filed by: Arroyo Ian
-
Form 6-K KOREA ELECTRIC POWER For: Oct 02
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 18-K/A QUEENSLAND TREASURY CORP For: Jun 30
-
Form DEFA14A SYNAPTICS Inc
-
Form RW ON SEMICONDUCTOR CORP
-
Form DEFM14A Utz Brands, Inc.
-
Form 6-K NIO Inc. For: Oct 02
-
Form EFFECT Polyrizon Ltd.
-
Form 6-K Addex Therapeutics Ltd. For: Oct 02
-
Form EFFECT Tempest Therapeutics,
-
Form 4 BHP Group Ltd For: Sep 30 Filed by: Stone Emma Kate
-
Form 4 Keysight Technologies, For: Sep 30 Filed by: Dhanasekaran Satish
-
Form QUALIF East West International,
-
Form DEF 14A GULF RESOURCES, INC. For: Oct 02
-
Form 424B2 JPMORGAN CHASE & CO
-
Form EFFECT NeoVolta Inc.
-
Form 6-K KB Financial Group Inc. For: Oct 02
-
Form 6-K KE Holdings Inc. For: Oct 02
-
Form 6-K BANCO BILBAO VIZCAYA For: Oct 02
-
Form 4 Alibaba Group Holding For: Sep 30 Filed by: Jiang Fang
-
Form EFFECT InMed Pharmaceuticals
-
Form EFFECT FDCTECH, INC.
-
Form EFFECT BANK OF NOVA SCOTIA
-
Form EFFECT FT 13230
-
Form EFFECT FT 13221
-
Form 8-K Flowco Holdings Inc. For: Oct 02
-
Form 424B2 JPMORGAN CHASE & CO

